These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16050493)

  • 21. The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
    Long J; Zhang DH; Zhang GH; Rao ZK; Wang YH; Tam SC; He YP; Zheng YT
    Yao Xue Xue Bao; 2010 Feb; 45(2):228-34. PubMed ID: 21348416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target-selective photodegradation of HIV-1 protease and inhibition of HIV-1 replication in living cells by designed fullerene-sugar hybrids.
    Tanimoto S; Sakai S; Kudo E; Okada S; Matsumura S; Takahashi D; Toshima K
    Chem Asian J; 2012 May; 7(5):911-4. PubMed ID: 22378594
    [No Abstract]   [Full Text] [Related]  

  • 23. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Ferro S; De Luca L; Lo Surdo G; Morreale F; Pannecouque C; Balzarini J; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(4):1459-67. PubMed ID: 24457088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of New Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives as Potent HIV-1 Maturation Inhibitors.
    Castro E; Martinez ZS; Seong CS; Cabrera-Espinoza A; Ruiz M; Hernandez Garcia A; Valdez F; Llano M; Echegoyen L
    J Med Chem; 2016 Dec; 59(24):10963-10973. PubMed ID: 28002960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and SARs of indole-based α-amino acids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Han X; Wu H; Wang W; Dong C; Tien P; Wu S; Zhou HB
    Org Biomol Chem; 2014 Nov; 12(41):8308-17. PubMed ID: 25209054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide inhibits the HIV-1 reverse transcriptase activity.
    Persichini T; Colasanti M; Fraziano M; Colizzi V; Medana C; Polticelli F; Venturini G; Ascenzi P
    Biochem Biophys Res Commun; 1999 May; 258(3):624-7. PubMed ID: 10329434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
    Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
    Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A search for anti-viral properties in Panamanian medicinal plants. The effects on HIV and its essential enzymes.
    Matsuse IT; Lim YA; Hattori M; Correa M; Gupta MP
    J Ethnopharmacol; 1999 Jan; 64(1):15-22. PubMed ID: 10075118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
    Wińska P; Miazga A; Poznański J; Kulikowski T
    Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
    Pereira CF; Paridaen JT; van de Bovenkamp M; Middel J; Verhoef J; Nottet HS
    J Antimicrob Chemother; 2003 May; 51(5):1181-9. PubMed ID: 12668583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
    Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The anti-HIV activity of glycyrrhizic acid penta-O-nicotinate].
    Pliasunova OA; Il'ina TV; Kiseleva IaIu; Fediuk NV; Baltina LA; Tolstikov GA; Pokrovskiĭ AG
    Vestn Ross Akad Med Nauk; 2004; (11):42-6. PubMed ID: 15651664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
    J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) chloride: An HIV-1 reverse transcriptase and protease inhibitor.
    Fonteh PN; Keter FK; Meyer D; Guzei IA; Darkwa J
    J Inorg Biochem; 2009 Feb; 103(2):190-4. PubMed ID: 19019450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.
    Lee JS; Hattori M; Kim J
    Planta Med; 2008 Apr; 74(5):532-4. PubMed ID: 18543149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.
    Hazen RJ; Harvey RJ; St Clair MH; Ferris RG; Freeman GA; Tidwell JH; Schaller LT; Cowan JR; Short SA; Romines KR; Chan JH; Boone LR
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4465-73. PubMed ID: 16251284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1.
    An T; Ouyang W; Pan W; Guo D; Li J; Li L; Chen G; Yang J; Wu S; Tien P
    Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides.
    Masuda N; Yamamoto O; Fujii M; Ohgami T; Fujiyasu J; Kontani T; Moritomo A; Orita M; Kurihara H; Koga H; Nakahara H; Kageyama S; Ohta M; Inoue H; Hatta T; Suzuki H; Sudo K; Shimizu Y; Kodama E; Matsuoka M; Fujiwara M; Yokota T; Shigeta S; Baba M
    Bioorg Med Chem; 2004 Dec; 12(23):6171-82. PubMed ID: 15519161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.